DE69334073D1 - Alkalimetall-8,9-Dehydroestronsulfatester - Google Patents

Alkalimetall-8,9-Dehydroestronsulfatester

Info

Publication number
DE69334073D1
DE69334073D1 DE69334073T DE69334073T DE69334073D1 DE 69334073 D1 DE69334073 D1 DE 69334073D1 DE 69334073 T DE69334073 T DE 69334073T DE 69334073 T DE69334073 T DE 69334073T DE 69334073 D1 DE69334073 D1 DE 69334073D1
Authority
DE
Germany
Prior art keywords
dehydroestronsulfatester
alkali metal
alkali
metal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69334073T
Other languages
English (en)
Other versions
DE69334073T2 (de
Inventor
Panolil Chirukan Raveendranath
John Anthony Wichtowski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
Wyeth LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth LLC filed Critical Wyeth LLC
Application granted granted Critical
Publication of DE69334073D1 publication Critical patent/DE69334073D1/de
Publication of DE69334073T2 publication Critical patent/DE69334073T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69334073T 1992-02-26 1993-02-19 Alkalimetall-8,9-Dehydroestronsulfatester Expired - Fee Related DE69334073T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US841694 1992-02-26
US07/841,694 US5210081A (en) 1992-02-26 1992-02-26 Alkali metal 8,9-dehydroestrone sulfate esters

Publications (2)

Publication Number Publication Date
DE69334073D1 true DE69334073D1 (de) 2006-11-23
DE69334073T2 DE69334073T2 (de) 2007-02-01

Family

ID=25285489

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69322497T Expired - Fee Related DE69322497T2 (de) 1992-02-26 1993-02-19 Alkali-metal, 8, 9-dehydroöstron-sulfat ester
DE69334073T Expired - Fee Related DE69334073T2 (de) 1992-02-26 1993-02-19 Alkalimetall-8,9-Dehydroestronsulfatester

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69322497T Expired - Fee Related DE69322497T2 (de) 1992-02-26 1993-02-19 Alkali-metal, 8, 9-dehydroöstron-sulfat ester

Country Status (22)

Country Link
US (3) US5210081A (de)
EP (2) EP0628052B1 (de)
JP (1) JP3715645B2 (de)
KR (1) KR100256861B1 (de)
AR (2) AR042262A2 (de)
AT (2) ATE174342T1 (de)
AU (2) AU677181B2 (de)
CA (1) CA2089707A1 (de)
DE (2) DE69322497T2 (de)
DK (2) DK0864583T3 (de)
ES (2) ES2274555T3 (de)
FI (1) FI115915B (de)
GR (1) GR3029620T3 (de)
HK (2) HK1011369A1 (de)
HU (2) HUT67553A (de)
LV (1) LV12240B (de)
MX (1) MX9300969A (de)
PT (1) PT864583E (de)
SG (1) SG49715A1 (de)
TW (1) TW257677B (de)
WO (1) WO1993017036A1 (de)
ZA (1) ZA93746B (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5210081A (en) * 1992-02-26 1993-05-11 American Home Products Corporation Alkali metal 8,9-dehydroestrone sulfate esters
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
DE4334823C2 (de) * 1993-10-09 1998-09-17 Schering Ag Verfahren zur Herstellung von Schwefelsäurehalbestern von Estrogenen
US5395831A (en) * 1994-04-08 1995-03-07 American Home Products Corporation Treating cardiac disorders with Δ9(11)-dehydro-8-isoestrone
US5861431A (en) * 1995-06-07 1999-01-19 Iotek, Inc. Incontinence treatment
US5998639A (en) * 1995-11-06 1999-12-07 Akzo Nobel, N.V. Sulfatation of estrogen mixtures
AU703814B2 (en) * 1995-12-04 1999-04-01 Wyeth Antioxidant
DE19631542C1 (de) * 1996-07-25 1997-08-28 Schering Ag Verfahren zur Herstellung von 3-Sulfatoxy-estra-1,3,5(10)-trien-Derivaten II
DE19631543C1 (de) * 1996-07-25 1997-11-20 Schering Ag Verfahren zur Herstellung von 3-Sulfatoxy-estra-1,3,5(10)-trien-Derivaten I
US6028064A (en) 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
ID18256A (id) * 1996-09-16 1998-03-19 American Home Prod Penggunaan dari 8,9-dehidro estron sebagai estrogen dengan hasil netral pada tingkat prolaktin
AR014096A1 (es) * 1996-10-11 2001-02-07 Wyeth Corp 17 alfa,8,9-deshidroestradiol y 17 beta delta 8,9 deshidroestradiol, el uso de los mismos para la manufactura de un medicamento, una composicionfarmaceutica que los comprende y un procedimiento para su preparacion.
ZA979204B (en) * 1996-10-16 1999-04-14 American Home Prod Use of 8,9-dehydroestrone in treating vasomotor symptoms
IL124213A (en) * 1997-05-02 2004-12-15 Akzo Nobel Nv Sulfation of estrogen mixtures
US6432643B1 (en) 1999-10-22 2002-08-13 Duke University Method of determining Alzheimer's disease risk using apolipoprotein E4 genotype analysis in combination with decreased estrogen levels
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US6660726B2 (en) 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US7989436B2 (en) * 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US6855703B1 (en) * 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20030158432A1 (en) * 2002-01-08 2003-08-21 Leonard Thomas W. Synthesis of a mixture of sulfated estrogens using a sulfur trioxide complex
US8349819B2 (en) * 2002-10-09 2013-01-08 Dr. Reddy's Laboratories New York, Inc. Steroid extraction process from urine sources
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
JP2006522833A (ja) * 2003-04-11 2006-10-05 バー・ラボラトリーズ，インコーポレイテッド エストロゲンおよびプロゲスチンの投与法
GT200500141A (es) * 2004-06-07 2006-01-10 Recubrimiento de azucar y metodos para la fabricacion de los mismos.
US20060040904A1 (en) * 2004-08-17 2006-02-23 Ahmed Salah U Vaginal cream compositions, kits thereof and methods of using thereof
CA2601773A1 (en) * 2005-02-03 2006-08-10 Duramed Pharmaceuticals, Inc. Compositions of unconjugated estrogens and methods for their use
JP2008545012A (ja) * 2005-06-29 2008-12-11 ワイス 結合型エストロゲンおよびバゼドキシフェンの医薬処方
WO2007076144A2 (en) * 2005-12-27 2007-07-05 Duramed Pharmaceuticals, Inc. Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof
US20080107780A1 (en) * 2006-11-07 2008-05-08 Wyeth Sugar coatings and methods therefor
KR20090104862A (ko) * 2007-01-12 2009-10-06 와이어쓰 정제내 정제 조성물
US20080194533A1 (en) * 2007-02-09 2008-08-14 Wyeth Process for selective sulfation of aromatic hydroxyl groups
US7902147B2 (en) 2007-11-05 2011-03-08 Duke University Chronic lymphocytic leukemia prognosis and treatment
EP2493477B1 (de) 2009-10-27 2013-10-16 Wyeth LLC Bazedoxifenformulierungen mit antioxidationsmitteln

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2834712A (en) * 1953-05-27 1958-05-13 American Home Prod Urinary estrogen compositions and methods for preparing them
US3079410A (en) * 1960-04-02 1963-02-26 Hoechst Ag Process for stabilizing anionic and cationic ester salts of 21-hydroxy-20-ketosteroids in an aqueous solution
US3959322A (en) * 1960-09-22 1976-05-25 Herchel Smith Synthesis of 13-alkyl-gon-4-ones
DE1200476B (de) * 1961-04-10 1965-09-09 Frosst & Co Charles E Stabilisierung von trockenen Zubereitungen synthetischer Alkalisalze von OEstronsulfat
US3551459A (en) * 1962-10-04 1970-12-29 Herchel Smith 13-methyl-8-isogonanes
US3394153A (en) * 1965-08-18 1968-07-23 Merck & Co Inc Process for the preparation of d, 1-8-dehydroestrone, and intermediates obtained therefrom
NL6805153A (de) * 1968-04-10 1969-10-14
US3644618A (en) * 1968-10-29 1972-02-22 Frosst & Co Charles E Stable composition of synthetic sodium estrone sulfate
US3608077A (en) * 1969-11-13 1971-09-21 Syntex Corp Stabilization of metal steroid alcohol sulfates
US3649621A (en) * 1969-12-19 1972-03-14 American Home Prod Novel 3-cyclopentyl ethers of 13-alkylgon-poly-enes
GB1451109A (en) * 1973-08-17 1976-09-29 Rech Et Dapplications Scient S Derivatives of oestrone and their use in therapy
GB1528321A (en) * 1975-07-07 1978-10-11 Leo Ab Acylation process for the preparation of phenolic n,n-di-substituted carbamate esters
SE439586B (sv) * 1975-09-05 1985-06-24 Kanebo Ltd Sett att framstella ett stabilt farmaceutiskt torrpreparat av ett alkalimetallsalt av dehydroepiandrosteronsulfat
US4154820A (en) * 1976-02-23 1979-05-15 Akzona Incorporated Compositions containing alkali metal sulfate salts of conjugated estrogens and antioxidants as stabilizers
US5210081A (en) * 1992-02-26 1993-05-11 American Home Products Corporation Alkali metal 8,9-dehydroestrone sulfate esters

Also Published As

Publication number Publication date
EP0864583B1 (de) 2006-10-11
FI115915B (fi) 2005-08-15
ZA93746B (en) 1994-08-03
AU711571B2 (en) 1999-10-14
DE69322497D1 (de) 1999-01-21
LV12240B (en) 1999-06-20
HK1020282A1 (en) 2000-04-07
DE69334073T2 (de) 2007-02-01
AR042262A2 (es) 2005-06-15
EP0628052B1 (de) 1998-12-09
DE69322497T2 (de) 1999-05-06
ATE342272T1 (de) 2006-11-15
MX9300969A (es) 1993-09-01
GR3029620T3 (en) 1999-06-30
ES2274555T3 (es) 2007-05-16
US5288717A (en) 1994-02-22
PT864583E (pt) 2007-01-31
DK0864583T3 (da) 2006-12-04
US6169082B1 (en) 2001-01-02
HU211971A9 (en) 1996-01-29
DK0628052T3 (da) 1999-07-12
EP0864583A2 (de) 1998-09-16
EP0864583A3 (de) 2004-07-21
JPH07504197A (ja) 1995-05-11
AR042345A2 (es) 2005-06-15
EP0628052A1 (de) 1994-12-14
AU2007697A (en) 1997-07-03
HK1011369A1 (en) 1999-07-09
HU9402457D0 (en) 1994-10-28
ES2125975T3 (es) 1999-03-16
CA2089707A1 (en) 1993-08-27
TW257677B (de) 1995-09-21
WO1993017036A1 (en) 1993-09-02
AU677181B2 (en) 1997-04-17
KR950700318A (ko) 1995-01-16
FI943903A0 (fi) 1994-08-25
LV12240A (lv) 1999-03-20
KR100256861B1 (ko) 2000-08-01
FI943903A (fi) 1994-08-25
HUT67553A (en) 1995-04-28
JP3715645B2 (ja) 2005-11-09
US5210081A (en) 1993-05-11
AU3726093A (en) 1993-09-13
ATE174342T1 (de) 1998-12-15
SG49715A1 (en) 1998-06-15

Similar Documents

Publication Publication Date Title
DE69334073D1 (de) Alkalimetall-8,9-Dehydroestronsulfatester
FI953489A (fi) 2,6-diaminopuriinijohdannaisia
FI934610A0 (fi) Ventilsammansaettning foer roerledning, omfattande loestagbart ventilsaete
NO932842D0 (no) 1,4-benzodioksanderivater
FI931747A0 (fi) Reflexkropp, isynnerhet foer vaegmarkeringar
DE59308564D1 (de) 2,4-Dialkyl-6-sec-alkylphenole
NO922578D0 (no) Sidehengslet, 1800 dreibart vindu
FI941909A (fi) 2,6-disubstituoidut 4-kinolyylidihydropyridiinit
FI934317A (fi) Farmaceutiska sammansaettningar, vilka innehaoller ej-joniska ytaktiva aemnen
NO944024L (no) 1,2-dihydro-2-okso-pyridin
NO943791D0 (no) 1,2-dihydro-2-okso-3-metylsulfonylaminometylpyridin
NO942212D0 (no) 13,14-dihydro-PGF2
FI266U1 (fi) Kapningsanordning foer aemnesbana, saosom en pappersbana
FI935129A0 (fi) Tvaovaoningsgodsvagn, saerskilt foer biltransport
ES1020681Y (es) Mueble-gimnasio.
ES1021196Y (es) Cubre-cajas pefeccionado.
FI784U1 (fi) Skalkonstruktion, speciellt vaeggkonstruktion, foer byggnad
SE9202883D0 (sv) Tving, roertving
SE9203391D0 (sv) Laangstraeckt, boejbart baerelement
NO932967L (no) Di- henholdsvis triazindioner
ES1022971Y (es) Perinola.
ES1021990Y (es) Estuche-expositor-sorpresa.
ES1020075Y (es) Columbario.
ES1020335Y (es) Estuche-escribania.
ES1028183Y (es) Venturi-caudalimetro.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee